MSDC-0160, a novel clinical-stage mitochondrial pyruvate carrier inhibitor, suppresses osteoclast differentiation and alleviates type 2 diabetes-related bone loss
MSDC-0160 是一种新型的临床阶段线粒体丙酮酸载体抑制剂,可抑制破骨细胞分化并减轻 2 型糖尿病相关的骨质流失。
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-026-07699-w
Wang, Chaofeng; Hai, Na; Chen, Liuyuan; Huang, Qian; Gui, Ying; Su, Yuangang; Lian, Haoyu; Liang, Jiamin; Zhao, Jinmin; Xu, Jiake; Liu, Qian